Cargando…

Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer

BACKGROUND: The distant metastasis was the most predictive characters of poor prognosis for triple‐negative breast cancer (TNBC). We aimed to evaluate the correlation between patient characters and preferential distant metastatic sites (DMS) and its effects on prognosis. METHODS: Using the 2010‐2014...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yaming, Su, Peng, Wang, Yifei, Zhang, Hanwen, Liang, Yiran, Zhang, Ning, Song, Xiaojin, Li, Xiaoyan, Li, Jie, Yang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997059/
https://www.ncbi.nlm.nih.gov/pubmed/31814295
http://dx.doi.org/10.1002/cam4.2759
_version_ 1783493614840578048
author Li, Yaming
Su, Peng
Wang, Yifei
Zhang, Hanwen
Liang, Yiran
Zhang, Ning
Song, Xiaojin
Li, Xiaoyan
Li, Jie
Yang, Qifeng
author_facet Li, Yaming
Su, Peng
Wang, Yifei
Zhang, Hanwen
Liang, Yiran
Zhang, Ning
Song, Xiaojin
Li, Xiaoyan
Li, Jie
Yang, Qifeng
author_sort Li, Yaming
collection PubMed
description BACKGROUND: The distant metastasis was the most predictive characters of poor prognosis for triple‐negative breast cancer (TNBC). We aimed to evaluate the correlation between patient characters and preferential distant metastatic sites (DMS) and its effects on prognosis. METHODS: Using the 2010‐2014 Surveillance, Epidemiology, and End Results Program (SEER) data, patients with TNBC were classified into eight histologic subtypes. Patient characters were compared using a chi‐squared test. Logistic regression was used for identification of predictive factors. The log‐rank testing was utilized with disease‐specific survival (DSS) and overall survival (OS) as the primary outcomes. RESULTS: A total of 23 270 patients with TNBC were involved, including 1544 patients with distant metastatic cancer. Bone metastasis was diagnosed in 559 cases, brain metastasis in 124 cases, liver metastasis found in 369 cases and lung metastasis in 492 cases. Histologic subtypes including metaplastic breast carcinoma and invasive lobular carcinoma showed significant differences in preferential DMS compared with invasive ductal carcinoma. Furthermore, we found different histologic subtypes with specific DMS showed various prognosis. We also evaluated different DMS of specific histologic subtypes showed different prognosis. CONCLUSION: Certain histologic subtypes of breast cancer are associated with preferential DMS and prognosis; this knowledge may help to further understand the mechanism of breast cancer metastasis and to monitor the prognosis of patients with TNBC.
format Online
Article
Text
id pubmed-6997059
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69970592020-02-05 Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer Li, Yaming Su, Peng Wang, Yifei Zhang, Hanwen Liang, Yiran Zhang, Ning Song, Xiaojin Li, Xiaoyan Li, Jie Yang, Qifeng Cancer Med Clinical Cancer Research BACKGROUND: The distant metastasis was the most predictive characters of poor prognosis for triple‐negative breast cancer (TNBC). We aimed to evaluate the correlation between patient characters and preferential distant metastatic sites (DMS) and its effects on prognosis. METHODS: Using the 2010‐2014 Surveillance, Epidemiology, and End Results Program (SEER) data, patients with TNBC were classified into eight histologic subtypes. Patient characters were compared using a chi‐squared test. Logistic regression was used for identification of predictive factors. The log‐rank testing was utilized with disease‐specific survival (DSS) and overall survival (OS) as the primary outcomes. RESULTS: A total of 23 270 patients with TNBC were involved, including 1544 patients with distant metastatic cancer. Bone metastasis was diagnosed in 559 cases, brain metastasis in 124 cases, liver metastasis found in 369 cases and lung metastasis in 492 cases. Histologic subtypes including metaplastic breast carcinoma and invasive lobular carcinoma showed significant differences in preferential DMS compared with invasive ductal carcinoma. Furthermore, we found different histologic subtypes with specific DMS showed various prognosis. We also evaluated different DMS of specific histologic subtypes showed different prognosis. CONCLUSION: Certain histologic subtypes of breast cancer are associated with preferential DMS and prognosis; this knowledge may help to further understand the mechanism of breast cancer metastasis and to monitor the prognosis of patients with TNBC. John Wiley and Sons Inc. 2019-12-09 /pmc/articles/PMC6997059/ /pubmed/31814295 http://dx.doi.org/10.1002/cam4.2759 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Li, Yaming
Su, Peng
Wang, Yifei
Zhang, Hanwen
Liang, Yiran
Zhang, Ning
Song, Xiaojin
Li, Xiaoyan
Li, Jie
Yang, Qifeng
Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
title Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
title_full Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
title_fullStr Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
title_full_unstemmed Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
title_short Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
title_sort impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997059/
https://www.ncbi.nlm.nih.gov/pubmed/31814295
http://dx.doi.org/10.1002/cam4.2759
work_keys_str_mv AT liyaming impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer
AT supeng impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer
AT wangyifei impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer
AT zhanghanwen impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer
AT liangyiran impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer
AT zhangning impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer
AT songxiaojin impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer
AT lixiaoyan impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer
AT lijie impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer
AT yangqifeng impactofhistotypesonpreferentialorganspecificmetastasisintriplenegativebreastcancer